| Systematic (IUPAC) name | |
|---|---|
| 17-Cyclopropylmethyl-6,7-dehydro-4,5-epoxy -3,14-dihydroxy-6,7,2',3'-indolomorphinan | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | IV |
| Identifiers | |
| CAS number | 111555-53-4 |
| ATC code | None |
| PubChem | CID 5497186 |
| IUPHAR ligand | 1641 |
| ChemSpider | 4593753 |
| ChEMBL | CHEMBL567175 |
| Chemical data | |
| Formula | C26H26N2O3 |
| Mol. mass | 414.496 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Naltrindole is a highly potent, highly selective delta opioid receptor antagonist used in biomedical research. On 17th may 2012 a paper was published in Nature with the structure of Naltrindole in complex with the the mouse δ-opioid G-protein coupled receptor, solved by x-ray crystallography. [1]
Since peptide compounds are unable to cross the blood–brain barrier, researchers developed naltrindole to be a non-peptide antagonist analog of the delta-preferring endogenous opiate enkephalin. Enkephalin contains an aromatic phenyl group on its Phe4 residue, which was hypothesized to be the "address" sequence responsible for the opiate's delta opioid receptor affinity[2]. Thus, attachment of a phenyl-containing indole molecule to the C-ring of naltrexone's morphinan base successfully produced a drug with the high receptor affinity of naltrexone, but which binds almost exclusively to the delta opioid receptor[3].
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)